Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation
1 clinical trials · Condition
◉ Watch Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation
| Record | Firm | Date |
|---|---|---|
| Expanded Access With ABT-888 (Veliparib) to Treat Metastatic Breast Cancer (NCT02985658) | University of Washington |
Track Metastatic Breast Cancer With BRCA 1 or BRCA 2 Genetic Mutation automatically
Every clearance here is in the API, with alerts when new ones post.